NCT00257023View on ClinicalTrials.gov

An Exploratory Study on the Safety and Effectiveness of Paliperidone in Patients With Schizophrenia

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

February 28, 2005

Study Completion Date

September 30, 2005

Conditions
Schizophrenia
Interventions
DRUG

paliperidone

Sponsors
All Listed Sponsors
lead

Janssen Pharmaceutical K.K.

INDUSTRY

NCT00257023 - An Exploratory Study on the Safety and Effectiveness of Paliperidone in Patients With Schizophrenia | Biotech Hunter | Biotech Hunter